RT Journal Article
SR Electronic
T1 Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10<sup>+</sup> advanced non-small cell lung cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003581
DO 10.1136/jitc-2021-003581
VO 10
IS 1
A1 Blumenschein, George R
A1 Devarakonda, Siddhartha
A1 Johnson, Melissa
A1 Moreno, Victor
A1 Gainor, Justin
A1 Edelman, Martin J
A1 Heymach, John V
A1 Govindan, Ramaswamy
A1 Bachier, Carlos
A1 Doger de Spéville, Bernard
A1 Frigault, Matthew J
A1 Olszanski, Anthony J
A1 Lam, Vincent K
A1 Hyland, Natalie
A1 Navenot, Jean-Marc
A1 Fayngerts, Svetlana
A1 Wolchinsky, Zohar
A1 Broad, Robyn
A1 Batrakou, Dzmitry
A1 Pentony, Melissa M
A1 Sanderson, Joseph P
A1 Gerry, Andrew
A1 Marks, Diane
A1 Bai, Jane
A1 Holdich, Tom
A1 Norry, Elliot
A1 Fracasso, Paula M
YR 2022
UL http://jitc.bmj.com/content/10/1/e003581.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.